HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of a flow cytometry-based pulse-width assay for detection of aggregates in cellular therapeutics to be infused by catheter.

AbstractBACKGROUND AIMS:
Delivery of cell-based therapies through the carotid artery with the use of an intra-arterial catheter could introduce aggregates and cause focal ischemia in the brain. We developed a pulse-width flow cytometry method for aggregate detection and quantification. The assay was designed to be used as a cell product release assay in a clinical trial seeking to treat ischemic stroke with sorted cells brightly expressing aldehyde dehydrogenase (ALDH(br) cells) delivered through intra-arterial catheters.
METHODS:
The forward light scatter pulse-width axis of a flow cytometer was calibrated for particle diameter measurements through the use of traceable standard microspheres and linear regression. As a positive control, Concanavalin A-aggregated cells were counted manually and sorted onto slides to compare with pulse width-determined values. Known numbers of aggregates were spiked into purified singlet cells for quantification. A clinical standard for aggregate count and diameter was determined. The assay was used to qualify catheters with the use of ALDH(br) cells.
RESULTS:
The pulse-width axis was highly linear for microsphere diameter (r(2) > 0.99), which allowed for size calibration. Microscopically determined counts and diameters corresponded to pulse width-determined values. Known aggregate counts were linear with pulse width-determined aggregate counts (r(2) = 0.98). The limit of detection was determined to be 0.004%. Flow of ALDH(br) cells through catheters did not generate aggregates. The final method to be used as a release assay for the stroke clinical trial was tested successfully on samples from volunteer donors.
CONCLUSIONS:
The pulse-width aggregate detection assay provides a reliable, reproducible, accurate and rapid means of detection, classification and quantification of aggregates in cell therapy products.
AuthorsDarren H M Hickerson, Hannah Storrie White, Alan Nguyen, Elizabeth Nieman, Norin Meadows, Tracy Gentry, Sandra J Foster, Andrew E Balber, Michelle Fiordalisi, James M Hinson Jr
JournalCytotherapy (Cytotherapy) Vol. 16 Issue 11 Pg. 1545-1557 (Nov 2014) ISSN: 1477-2566 [Electronic] England
PMID24972743 (Publication Type: Journal Article)
CopyrightCopyright © 2014 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Aldehyde Dehydrogenase
Topics
  • Aldehyde Dehydrogenase (biosynthesis, isolation & purification)
  • Bone Marrow Cells (pathology)
  • Brain Ischemia (diagnosis, immunology)
  • Catheters (adverse effects)
  • Cell Aggregation
  • Cell- and Tissue-Based Therapy (adverse effects)
  • Flow Cytometry
  • Gene Expression Regulation
  • Humans
  • Limit of Detection
  • Stem Cells (pathology)
  • Stroke (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: